The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-(1H-Indol-3-yl)-1-(5-methoxy-1H-indol-3-yl)pentane-1,2-dione ID: ALA3809783
PubChem CID: 127044905
Max Phase: Preclinical
Molecular Formula: C22H20N2O3
Molecular Weight: 360.41
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc2[nH]cc(C(=O)C(=O)CCCc3c[nH]c4ccccc34)c2c1
Standard InChI: InChI=1S/C22H20N2O3/c1-27-15-9-10-20-17(11-15)18(13-24-20)22(26)21(25)8-4-5-14-12-23-19-7-3-2-6-16(14)19/h2-3,6-7,9-13,23-24H,4-5,8H2,1H3
Standard InChI Key: NRIAUEWTAVIVLL-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
2.1812 2.6271 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6500 2.9355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1182 4.3614 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5870 4.6698 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0553 6.0958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3808 3.5211 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.4505 2.0415 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 -1.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5889 0.0182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 1.2033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 -1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6217 1.4865 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.6560 0.8780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8979 6.1371 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.5884 5.4002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5241 6.4042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1136 7.7632 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4934 9.1333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3975 10.3548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8837 10.1920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5019 8.8037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5997 7.6004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
1 6 2 0
2 7 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
8 16 1 0
11 16 2 0
17 18 1 0
13 17 1 0
1 10 1 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
19 27 1 0
22 27 2 0
5 21 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 360.41Molecular Weight (Monoisotopic): 360.1474AlogP: 4.43#Rotatable Bonds: 7Polar Surface Area: 74.95Molecular Species: NEUTRALHBA: 3HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.80CX Basic pKa: ┄CX LogP: 4.58CX LogD: 4.58Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.38Np Likeness Score: -0.10
References 1. Tantak MP, Gupta V, Nikhil K, Arun V, Singh RP, Jha PN, Shah K, Kumar D.. (2016) Sequential one-pot synthesis of bis(indolyl)glyoxylamides: Evaluation of antibacterial and anticancer activities., 26 (13): [PMID:27173802 ] [10.1016/j.bmcl.2016.04.080 ]